1.13
Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
35.00
|
- | - | 0.09 | - |
| Operating Expenses |
25.95%
7.435
|
5.903 | 6.414 | 5.782 | 7.503 |
| Operating Income/Loss |
566.97%
27.57
|
-5.903 | -6.414 | -5.692 | -7.503 |
| Nonoperating Income/Loss |
11.81%
0.336
|
0.381 | 0.474 | 0.561 | 0.625 |
| Net Income/Loss |
605.27%
27.90
|
-5.522 | -5.94 | -5.131 | -6.878 |
| Basic Average Shares |
0.52%
31.40
|
31.24 | - | 31.20 | 31.20 |
| Diluted Average Shares |
0.54%
31.41
|
31.24 | - | 31.20 | 31.20 |
| Basic Earnings Per Share |
594.44%
0.89
|
-0.18 | - | -0.16 | -0.22 |
| Diluted Earnings Per Share |
594.44%
0.89
|
-0.18 | - | -0.16 | -0.22 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):